Z-11 trial and rethinking axillary reverse mapping Masakuni Noguchi Editorial 11 January 2015 Pages: 99 - 100
HER2-directed therapy: current treatment options for HER2-positive breast cancer Shahid AhmedAmer SamiJim Xiang Review Article 30 January 2015 Pages: 101 - 116
Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma Thi-Ngoc Diem VoEiji MekataTohru Tani Original Article 11 April 2013 Pages: 117 - 128
Visual assessment of Ki67 at a glance is an easy method to exclude many luminal-type breast cancers from counting 1000 cells Akira I. HidaYumi OshiroTakuya Moriya Original Article 31 March 2013 Pages: 129 - 134
Utility of one-step nucleic acid amplification (OSNA) assay in detecting breast cancer metastases of sentinel lymph nodes in a Chinese population Dali LiXiaoli XuDaren Shi Original Article 21 March 2013 Pages: 135 - 140
Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptor-positive, HER2-negative, node-negative invasive breast cancers Makiko OnoHitoshi TsudaYasuhiro Fujiwara Original Article 13 April 2013 Pages: 141 - 152
Interobserver variability of ultrasound elastography and the ultrasound BI-RADS lexicon of breast lesions Chang Suk ParkSung Hun KimHyun Seouk Jung Original Article 13 April 2013 Pages: 153 - 160
Divisional role of quantitative HER2 testing in breast cancer Mutsuko Yamamoto-IbusukiYutaka YamamotoHirotaka Iwase Original Article 20 April 2013 Pages: 161 - 171
Breast cancer screening and the changing population pyramid of Japan Ken UchidaHitoshi OhashiHiroshi Takeyama Original Article 30 April 2013 Pages: 172 - 176
A combination of aprepitant, palonosetron, and dexamethasone prevents emesis associated with anthracycline-containing regimens for patients with breast cancer. A retrospective study Yoshie NakayamaYoshinori ItoKiyohiko Hatake Original Article 08 May 2013 Pages: 177 - 184
Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer Tatsuya YoshiokaMitsuchika HosodaHiroko Yamashita Original Article 05 May 2013 Pages: 185 - 191
Efficacy, safety, pharmacokinetics and biomarker findings in patients with HER2-positive advanced or metastatic breast cancer treated with lapatinib in combination with capecitabine: results from 51 Japanese patients treated in a clinical study Hiroji IwataHirofumi FujiiSeigo Nakamura Original Article Open access 21 May 2013 Pages: 192 - 200
Malignant lymphoma of the breast in a male patient: ultrasound imaging features Tatsuhiko IkedaHiroko BandoHisato Hara Case Report 07 March 2012 Pages: 201 - 205
Metastatic breast carcinoma of the abdominal wall muscle: a case report Akiko OgiyaKaoru TakahashiSeiji Yamasaki Case Report 02 March 2012 Pages: 206 - 209